TCL-137: Duvelisib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma: Final Results From the Phase 2 PRIMO Trial

Authors:
  • LPLauren C. Pinter-Brown
    Lauren C. Pinter-Brown
  • NMNeha Mehta-Shah
    Neha Mehta-Shah
  • PZPier Luigi Zinzani
    Pier Luigi Zinzani
  • EJEric D. Jacobsen
    Eric D. Jacobsen
  • JZJasmine Zain
    Jasmine Zain
  • MMMonica Mead
    Monica Mead
  • CCCarla Casulo
    Carla Casulo
  • GGGiuseppe Gritti
    Giuseppe Gritti
  • KIKoji Izutsu
    Koji Izutsu
  • OBOhad S. Bentur
    Ohad S. Bentur
  • DSDavid Sidransky
    David Sidransky
  • MAMichael Andria
    Michael Andria
Publisher website
Google Scholar
Abstract
No abstract available